• 1-800-526-8630U.S. (TOLL FREE)
  • 1-917-300-0470EAST COAST U.S.
  • +353-1-416-8900REST OF WORLD
Androgenic Alopecia - Pipeline Review, H2 2012 Product Image

Androgenic Alopecia - Pipeline Review, H2 2012

  • ID: 2366332
  • December 2012
  • 50 pages
  • Global Markets Direct

Androgenic Alopecia – Pipeline Review, H2 2012

Summary

Global Markets Direct’s, 'Androgenic Alopecia - Pipeline Review, H2 2012', provides an overview of the indication’s therapeutic pipeline. This report provides information on the therapeutic development for Androgenic Alopecia, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Androgenic Alopecia. Androgenic Alopecia - Pipeline Review, Half Year is built using data and information sourced from Global Markets Direct’s proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct’s team.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- A snapshot of the global therapeutic scenario for Androgenic Alopecia.
- A review of the Androgenic Alopecia products under development by companies and universities/research READ MORE >

2
List of Tables 4
List of Figures 5
Introduction 6
REPORT COVERAGE 6
Androgenic Alopecia Overview 7
Therapeutics Development 8
An Overview of Pipeline Products for Androgenic Alopecia 8
Androgenic Alopecia Therapeutics under Development by Companies 10
Androgenic Alopecia Therapeutics under Investigation by Universities/Institutes 11
Mid Clinical Stage Products 12
Comparative Analysis 12
Early Clinical Stage Products 13
Comparative Analysis 13
Discovery and Pre-Clinical Stage Products 14
Comparative Analysis 14
Androgenic Alopecia Therapeutics – Products under Development by Companies 15
Androgenic Alopecia Therapeutics – Products under Investigation by Universities/Institutes 16
Companies Involved in Androgenic Alopecia Therapeutics Development 17
Histogen, Inc. 17
HYUNDAI PHARM. CO., LTD. 18
Hygeia Therapeutics, Inc. 19
GliaMed, Inc. 20
Aderans Research Institute 21
Androgenic Alopecia – Therapeutics Assessment 22
Assessment by Monotherapy Products 22
Assessment by Combination Products 23
Assessment by Route of Administration 24
Assessment by Molecule Type 26
Drug Profiles 28
GM-1485 - Drug Profile 28
Product Description 28
Mechanism of Action 28
R&D Progress 28
HYG-440 - Drug Profile 30
Product Description 30
Mechanism of Action 30
R&D Progress 30
HYG-102440 - Drug Profile 32
Product Description 32
Mechanism of Action 32
R&D Progress 32
Ji GamiDO + Minoxidil - Drug Profile 33
Product Description 33
Mechanism of Action 33
R&D Progress 33
Ji Gami CN - Drug Profile 34
Product Description 34
Mechanism of Action 34
R&D Progress 34
Ji Gami N - Drug Profile 35
Product Description 35
Mechanism of Action 35
R&D Progress 35
Ji Gami C - Drug Profile 36
Product Description 36
Mechanism of Action 36
R&D Progress 36
Ji Gami - Drug Profile 37
Product Description 37
Mechanism of Action 37
R&D Progress 37
Ji Gami DO - Drug Profile 38
Product Description 38
Mechanism of Action 38
R&D Progress 38
Autologous Human Platelet Lysate - Drug Profile 39
Product Description 39
Mechanism of Action 39
R&D Progress 39
Hair Stimulating Complex (HSC) - Drug Profile 40
Product Description 40
Mechanism of Action 40
R&D Progress 40
Ji Gami NDO - Drug Profile 41
Product Description 41
Mechanism of Action 41
R&D Progress 41
HOB-058 - Drug Profile 43
Product Description 43
Mechanism of Action 43
R&D Progress 43
Androgenic Alopecia Therapeutics – Drug Profile Updates 44
Androgenic Alopecia Therapeutics - Dormant Products 45
Androgenic Alopecia – Product Development Milestones 46
Featured News & Press Releases 46
Oct 19, 2012: Histogen Announces Initial Results From Phase I/II Clinical Trial Of HSC In Androgenetic Alopecia 46
Apr 13, 2010: HSC Trial Shows Continued Significant Hair Growth at One Year Follow-up 47
Jul 27, 2009: Histogen Hair Regrowth Clinical Trial Presented at ISHRS Annual Meeting 48
Appendix 49
Methodology 49
Coverage 49
Secondary Research 49
Primary Research 49
Expert Panel Validation 49
Contact Us 50
Disclaimer 50

List of Tables
Number of Products Under Development for Androgenic Alopecia, H2 2012 8
Products under Development for Androgenic Alopecia – Comparative Analysis, H2 2012 9
Number of Products under Development by Companies, H2 2012 10
Number of Products under Investigation by Universities/Institutes, H2 2012 11
Comparative Analysis by Mid Clinical Stage Development, H2 2012 12
Comparative Analysis by Early Clinical Stage Development, H2 2012 13
Comparative Analysis by Discovery and Pre-Clinical Stage Development, H2 2012 14
Products under Development by Companies, H2 2012 15
Products under Investigation by Universities/Institutes, H2 2012 16
Histogen, Inc., H2 2012 17
HYUNDAI PHARM. CO., LTD., H2 2012 18
Hygeia Therapeutics, Inc., H2 2012 19
GliaMed, Inc., H2 2012 20
Aderans Research Institute, H2 2012 21
Assessment by Monotherapy Products, H2 2012 22
Assessment by Combination Products, H2 2012 23
Assessment by Stage and Route of Administration, H2 2012 25
Assessment by Stage and Molecule Type, H2 2012 27
Androgenic Alopecia Therapeutics – Drug Profile Updates 44
Androgenic Alopecia Therapeutics – Dormant Products 45

List of Figures
Number of Products under Development for Androgenic Alopecia, H2 2012 8
Products under Development for Androgenic Alopecia – Comparative Analysis, H2 2012 9
Products under Development by Companies, H2 2012 10
Products under Investigation by Universities/Institutes, H2 2012 11
Mid Clinical Stage Products, H2 2012 12
Early Clinical Stage Products, H2 2012 13
Discovery and Pre-Clinical Stage Products, H2 2012 14
Assessment by Monotherapy Products, H2 2012 22
Assessment by Combination Products, H2 2012 23
Assessment by Route of Administration, H2 2012 24
Assessment by Stage and Route of Administration, H2 2012 25
Assessment by Molecule Type, H2 2012 26
Assessment by Stage and Molecule Type, H2 2012 27

Note: Product cover images may vary from those shown

RELATED PRODUCTS

Our Clients

Our clients' logos